The Many Faces of Covid-19: Organizing Pneumonia (OP) Pattern HRCT Features

G Rea1, Tullio Valente1, R Lieto1

  • 1Dipartimento di Radiologia, Ospedale Monaldi, A.O. dei Colli, Napoli, Italia.

Insights

This case study highlights a 57-year-old male with Covid-19 (coronavirus disease 2019). High-resolution computed tomography (HRCT) revealed a typical organizing pneumonia (OP) reaction, emphasizing its role in disease assessment.

Area of Science:

  • Radiology
  • Infectious Diseases
  • Pulmonology

Background:

  • Coronavirus disease 2019 (Covid-19) is a significant global health concern caused by SARS-CoV-2.
  • The respiratory system is primarily affected, making chest imaging crucial for diagnosis and monitoring.
  • The World Health Organization declared Covid-19 a public health emergency in January 2020.

Purpose of the Study:

  • To present a case of Covid-19 in a 57-year-old male.
  • To illustrate the characteristic high-resolution computed tomography (HRCT) findings.
  • To document the organizing pneumonia (OP) reaction in a Covid-19 patient.

Main Methods:

  • Case report of a 57-year-old male Covid-19 patient.
  • Utilized high-resolution computed tomography (HRCT) for imaging.
  • Observed the course of organizing pneumonia (OP) reaction.

Main Results:

  • The patient presented with Covid-19.
  • HRCT demonstrated a typical course of organizing pneumonia (OP) reaction.
  • Imaging findings correlated with the clinical presentation of SARS-CoV-2 infection.

Conclusions:

  • Chest CT, particularly HRCT, is vital for evaluating Covid-19.
  • Organizing pneumonia (OP) is a recognized HRCT pattern in Covid-19 patients.
  • This case underscores the utility of HRCT in assessing SARS-CoV-2 related lung changes.

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
1.8K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.6K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
498
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
603
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.7K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
583